ARCHIVES

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

This article is from The Cancer Letter archive.

Vol. 05 No. 42 | October 19, 1979

Download PDF Visit The Full Archive

Related Articles

Texas Cancer Plan Features Big Hike in Cigarette Tax

September 19, 1986

Sunitinib Prolongs Survival In Poor Prognosis, Study Finds

July 31, 2009

Community Assn. Meeting Includes Provocative Workshops

January 31, 1975

NCI Denies GAO Report That Backlog Still Exists, Says Most were Published As Research Results

May 18, 1979

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014